The Treatment of Neuroleptic Malignant Syndrome are Dantrolene and Bromocriptine Useful Adjuncts to Supportive Care?
- 1 November 1991
- journal article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 159 (5) , 709-712
- https://doi.org/10.1192/bjp.159.5.709
Abstract
In a prospective study of 20 patients with NMS, those who received dantrolene (2 patients) or bromocriptine (2 patients) or both (4 patients) tended to have a more prolonged course of illness and a greater incidence of sequelae than those treated with supportive care alone. These results do not indicate a useful role for dantrolene or bromocriptine in the treatment of NMS.Keywords
This publication has 4 references indexed in Scilit:
- Neuroleptic Malignant SyndromeArchives of internal medicine (1960), 1989
- The role of external heat load in triggering the neuroleptic malignant syndromeAmerican Journal of Psychiatry, 1988
- Comparative Doses and Costs of Antipsychotic MedicationArchives of General Psychiatry, 1976
- Procedures for Detecting Outlying Observations in SamplesTechnometrics, 1969